Convergence Technology Fund

Management

Fund classes:
NSF SICAV - Convergence Technology Fund - Class A EUR Acc
€1,065.73 Price
€-3.92
-0.37%
Today's Change
ISIN LU2206590544
Share Class Accumulation
Ongoing Charge 2.12%
Annual Management Charge 1.49%

Fund management breakdown

Manager Company Nevastar Finance
Fund Type SICAV
Benchmark Sector Equity Technology
Domicile LUX
For Sale in Switzerland, Spain, France, United Kingdom, Luxembourg

Fund manager biographies

Name Not Disclosed
Since 30 September 2020
Bio

Fund objective

The Sub-Fund's investment objective is to achieve over the medium to longterm capital appreciation by investing in equity securities of US and non US companies that are expected to benefit from the development, advancement and use of technology with a focus to artificial intelligence, automation, robotics, machine learning, algorithm, bionics, healthcare, genomics, biotech, healthcare innovation, cybersecurity, internet of things, virtual reality, innovation, 3D printing and other technology related companies. In addition, and in limited circumstances, the Sub-Fund may invest in equity and equity related securities of companies located in emerging countries which are listed on recognised stock exchanges of developed countries.